- JAZZ
- JAZZ PHARMACEUTICALS PLC
-
112.08+6.15 (+5.81%) 08/07 close, EST
- Signals
- Analysis
- Financials
- Charts
- Dividends
- Annualized
- Annual
- Quarterly
Income Statement million USD
| 06/30/25 | 03/31/25 | 12/31/24 | 09/30/24 | 06/30/24 | |
|---|---|---|---|---|---|
| Revenue | 4,087 | 4,065 | 4,069 | 3,993 | 3,910 |
| Cost of Revenue | 461 | 455 | 446 | 424 | 415 |
| Gross Profit | 3,625 | 3,610 | 3,623 | 3,568 | 3,495 |
| SG&A | 1,567 | 1,548 | 1,385 | 1,412 | 1,395 |
| R&D | 811 | 842 | 884 | 860 | 895 |
| Operating Income | -291 | 595 | 717 | 648 | 561 |
| EBITDA | 371 | 1,249 | 1,367 | 1,305 | 1,214 |
| Other Income Exp | -10 | -8 | -10 | 5 | 5 |
| intexp | 211 | 226 | 238 | 257 | 270 |
| Tax Expense | -107 | -121 | -91 | -67 | -99 |
| Discontinued Ops | 0 | 0 | 0 | 0 | 0 |
| Net Income | -405 | 482 | 560 | 463 | 395 |
Balance Sheet million USD
| 06/30/25 | 03/31/25 | 12/31/24 | 09/30/24 | 06/30/24 | |
|---|---|---|---|---|---|
| Cash, Cash Equivalents | 1,190 | 1,862 | 2,413 | 2,218 | 1,356 |
| Short-Term Investments | 480 | 710 | 580 | 400 | 625 |
| Receivables | 714 | 653 | 717 | 724 | 698 |
| Inventory | 505 | 493 | 480 | 539 | 543 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Net PPE | 248 | 228 | 227 | 254 | 242 |
| Intangible Assets | 6,613 | 6,478 | 6,472 | 6,949 | 6,815 |
| Deferred Tax Assets | 603 | 575 | 560 | 583 | 545 |
| Others Assets | 591 | 536 | 563 | 589 | 537 |
| Total Assets | 10,944 | 11,535 | 12,012 | 12,256 | 11,362 |
| Payables | 89 | 96 | 78 | 85 | 97 |
| Total Debt | 5,419 | 5,406 | 6,148 | 6,183 | 5,774 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 761 | 703 | 695 | 847 | 827 |
| Other Liabilities | 969 | 1,155 | 998 | 970 | 900 |
| Total Liabilities | 7,238 | 7,360 | 7,919 | 8,085 | 7,599 |
| Paid-in Capital + APIC |
4,000 | 3,926 | 3,914 | 3,838 | 3,780 |
| Retained Earnings | 191 | 1,035 | 1,127 | 936 | 871 |
| AOCI | -486 | -786 | -948 | -603 | -888 |
| Total Equity | 3,706 | 4,175 | 4,094 | 4,171 | 3,763 |
| Shares Outstanding | 6,119 | 6,097 | 6,600 | 6,317 | 6,962 |
Cash Flow Statement million USD
| 06/30/25 | 03/31/25 | 12/31/24 | 09/30/24 | 06/30/24 | |
|---|---|---|---|---|---|
| Operating Cash Flow | 1,316 | 1,558 | 1,396 | 1,165 | 1,073 |
| Investing Cash Flow | -789 | -405 | -508 | -213 | -601 |
| Financing Cash Flow | -700 | -736 | 21 | -72 | -396 |
| Effect of Exchange Rate | 7 | 2 | -2 | 2 | -2 |
| Net Increase/Decrease in Cash | -166 | 419 | 907 | 882 | 73 |
| Capital Expenditures | -51 | -45 | -38 | -35 | -28 |
| Free Cash Flow | 1,265 | 1,513 | 1,358 | 1,130 | 1,045 |
AI Signals